MedTech

TestCard launches at-home 'Test and Treat' UTI service

Medtech enterprise TestCard has launched a ‘Test and Treat’ service using its at-home UTI test kit in partnership with European digital healthcare provider, Zava. Zava’s telemedicine platform provides access to consultations, testing and prescribed treatments from UK-based, GMC registered GPs. Since 2011, Zava’s doctors have carried out almost 5 million consultations. TestCard turns a smartphone […]

Government launches nationwide antibody testing programme

The UK Health Security Agency will work alongside NHS Test and Trace testing services in England, Scotland, Wales and Northern Ireland to monitor levels of antibodies in positive cases across the UK. The data collected will help estimate the proportion of those who got COVID-19 despite developing antibodies as a result of having a vaccine or […]

$4.5m tech fund aims to revolutionise asthma self-management

Asthma UK and British Lung Foundation has announced the winners of their $4.5 million asthma tech fund which aims to kick-start a revolution in asthma self-management. Asthma affects 5.4 million people in the UK and results in around 70,000 hospital admissions and 1,100 deaths every year. It is a common condition that has the potential […]

Depression therapy firm Flow closes Series A investment round

Flow Neuroscience, creator of a medically approved transcranial direct current stimulation (tDCS) device and behavioural therapy app for depression, has closed its Series A investment round led by Khosla Ventures, CSS group through Swiss Health Ventures and Zühlke Ventures. The funding will advance its existing depression treatment to be more patient-specific and will accelerate the […]

Cloud & 5G to allow for 765 million teleconsultations globally by 2025

Many tech enthusiasts consider that the COVID-19 pandemic hit the world at just the right time, describing it as the spark that ignited a tidal wave of disruptive technological innovations.   Rollout of services and products were accelerated at a skyrocketing pace trickling down to a myriad of other solutions that would have taken years to hit the […]

Researchers found Juno, spin-off developing 'incubator 2.0'

Premature birth is a major problem worldwide, one in ten children are born prematurely. Currently, babies born between 24 and 37 weeks are cared for in neonatal intensive care units (NICUs) that support cardiac and respiratory development using incubators. This solution is not optimal for babies born extremely pre-term, or less than 28 weeks. At […]

Sleep therapy device raises over $315.38 in crowdfunding

A UK-designed sleep therapy solution with global ambitions raised over $314.21 in the first week of a Crowdcube crowdfunding campaign. SleepCogni, a portable device with data support for people suffering from insomnia, has so far attracted funds from 157 different investors in this latest fundraiser that combines venture capital investments and crowdfunding. The firm’s latest […]

Pfizer vaccine efficacy falls to 84% after 6 months

Pfizer and BioNTech published on Wednesday new data indicating their COVID-19 vaccine efficacy decline from 96 percent to 84 percent over six months. These numbers are regarded as a big motivator to the drug makers currently developing a third “booster shot” to target the Indian Delta variant.  The released data shows that the antibody levels […]

Google delays return to office, mandates vaccines

Google is postponing a return to the office for most workers until mid-October and rolling out a policy that will eventually require everyone to be vaccinated once its sprawling campuses are fully reopened. The more highly contagious delta variant of the coronavirus is driving a dramatic spike in COVID-19 cases and hospitalizations. Google’s Wednesday announcement […]

Vaccine maker BioNTech to use mRNA tech to target malaria

Pharmaceutical company BioNTech said Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria. The Germany-based company, which developed the first widely approved coronavirus shot together with U.S. partner Pfizer, aims to begin clinical trials for a “safe and highly effective malaria vaccine” by the end of next year. […]